Analyst picks & changes

Agouron Pharmaceuticals Inc.

Edward Hurwitz of Robertson Stephens initiated coverage of Agouron Pharmaceuticals Inc. with a "buy" in anticipation of mounting enthusiasm for HIV

Read the full 238 word article

How to gain access

Continue reading with a
two-week free trial.